RateCaptain
  • Home
    • About Us
    • Contact Us
  • FX Rates
  • Money Market
  • Cryptocurrency
  • Commodities
  • Corporates
No Result
View All Result
Subscribe
  • Home
    • About Us
    • Contact Us
  • FX Rates
  • Money Market
  • Cryptocurrency
  • Commodities
  • Corporates
No Result
View All Result
RateCaptain
No Result
View All Result
Home Banking

Emzor’s $23 Million Plant: A Dollar-Saving Initiative That Will Also Save Lives

Stephen Akudike by Stephen Akudike
October 19, 2023
in Banking, company news, Economy
Reading Time: 3 mins read
A A
0
Emzor’s $23 Million Plant: A Dollar-Saving Initiative That Will Also Save Lives
Share on FacebookShare on TwitterShare on WhatsappShare on Telegram

Explore how Emzor’s multi-million-dollar pharmaceutical plant project not only aims to save valuable foreign currency but also contributes to improving healthcare and saving lives in Nigeria.Nigeria is poised to transform into a hub for Active Pharmaceutical Ingredients (API) manufacturing in sub-Saharan Africa, with the ambitious goal of achieving this milestone by the first quarter of 2024. This significant development is driven by a private-sector investment backed by the European Investment Bank (EIB), marking a crucial turning point in the country’s pharmaceutical landscape.

The transformation comes after decades of Nigeria grappling with a critical shortfall in its drug production process, heavily reliant on imports. Emzor Pharmaceutical Industries Limited has taken a pioneering step by securing a €13.85 million EIB loan to establish a $23 million API manufacturing plant, which is nearing completion.

AlsoRead

Nigeria Launches N50 Billion Green Bond to Fund Climate-Friendly Projects

Nigerian Banks Face N3.77 Trillion in Loan Losses Since 2023

CBN Crackdown: Nigerian Banks Face Dividend Freeze Until 2028

The EIB loan covers up to 60 percent of the project, which will initially focus on the production of four essential anti-malaria APIs: artemether, lumefantrine, sulfadoxine, and pyrimethamine. This effort will create over 500 jobs and eventually extend into three more key areas, contributing significantly to Nigeria’s pharmaceutical manufacturing capabilities.

Construction engineers on-site have reported that the two-phased plant will be fully operational by February. Equipped with cutting-edge technology and a skilled workforce, the facility is set to produce 200 metric tonnes of APIs annually. This substantial volume will reduce Nigeria’s dependency on imports, considering that the country currently imports over 90 percent of its APIs.

To put this into perspective, the value of imported finished drugs, such as artemether/lumefantrine, grew from N6.4 billion in 2018 to N12.1 billion in 2021, based on data from the National Agency for Food and Drug Administration and Control (NAFDAC). For finished drugs like sulfadoxine and pyrimethamine, Nigeria’s imports increased from N453 million in 2018 to N1.3 billion in 2021.

Local production of these critical APIs offers several advantages, including eliminating a commercial transaction where profits are taken out of the value chain. This not only reduces costs but also provides Nigerian drug manufacturers with a competitive edge against imported products, primarily from India and China.

Emeka Okoli, Chairman of Emzor Pharmaceutical Industries, anticipates that at full operating capacity, local production will become significantly more cost-effective than imports. He highlights the dual benefit of saving on input costs and retaining profits within the Nigerian market, ultimately creating a more competitive landscape.

Another significant advantage of local API production is the ability to cater to smaller manufacturers that cannot afford large consignments required for foreign orders. This could have a profound impact on expanding access to APIs within the country.

In the past, the pharmaceutical industry has called for Nigeria to prioritize drug security, given the historical neglect of healthcare by successive governments. The high cost of APIs has been a significant challenge for the industry, further compounded by the devaluation of the Nigerian Naira. This cost inevitably trickles down to the price of finished pharmaceutical products.

The successful establishment of API production in Nigeria is expected to align with the pricing of Indian and Chinese competitors. It is also essential that the quality of locally produced APIs matches or exceeds the standards set by existing products in the market.

The estimated value of the pharmaceutical market in Africa is approximately $30 billion, as per the 2023 edition of the Africa Pharmaceutical Market Outlook. Surprisingly, Nigeria represents just 1.5 percent of this market, lagging behind South Africa (3.9 percent), Egypt (2.6 percent), Algeria (1.9 percent), and Morocco (1.6 percent).

Despite hosting about 150 pharmaceutical manufacturers, the highest in sub-Saharan Africa, only 25 percent of drugs available in Nigeria are sourced locally. This contrasts with South Africa, where approximately 80 percent of medicines are sourced locally, largely due to the presence of advanced technical infrastructure and adequate manpower for synthesizing essential APIs.

The need for self-sufficiency in pharmaceuticals became apparent during the COVID-19 pandemic when the supply chain of key raw materials was disrupted. Nigeria and other African nations were forced to rely on aid to access life-saving vaccines. Additionally, non-communicable diseases have been on the rise, with African countries, including Nigeria, contributing significantly to the global burden.

 

Tags: #Nigeriadollar-saving initiativeeconomic impactEmzorHealthcarelife-savingmedical advancementsPharmaceutical Industrypharmaceutical plant
Previous Post

Coinbase Chooses Ireland as Its EU Hub Amid Regulatory Changes

Next Post

Patricia Urge Customers to Exchange Supposed ₦2 Billion Debt for Company Shares

Related News

DMO Announces Subscription Offering for Federal Government Savings Bonds.

Nigeria Launches N50 Billion Green Bond to Fund Climate-Friendly Projects

by Stephen Akudike
June 17, 2025
0

The Federal Government of Nigeria, through the Debt Management Office (DMO), has introduced a N50 billion Green Bond to finance...

Liquidity Crunch: Banking Sector’s Borrowing from CBN Surges to N12 Trillion.

Nigerian Banks Face N3.77 Trillion in Loan Losses Since 2023

by Jide Omodele
June 17, 2025
0

Ten commercial banks listed on the Nigerian Exchange (NGX) have collectively incurred N3.77 trillion in loan impairment charges from 2023...

CBN’s Recapitalization Budget of $1 Trillion Sparks Debate Among Industry Stakeholders

CBN Crackdown: Nigerian Banks Face Dividend Freeze Until 2028

by Stephen Akudike
June 17, 2025
0

A recent Renaissance Capital (Rencap) research note, titled “Nigerian Banks, Cash is King,” has shed light on the significant exposure...

Israel-Iran Conflict Poses Mixed Economic Impacts for Nigeria

by Stephen Akudike
June 16, 2025
0

The brewing conflict between Israel and Iran is sending shockwaves through global markets, and Nigeria, as a major oil-exporting nation,...

Next Post
Patricia Urge Customers to Exchange Supposed ₦2 Billion Debt for Company Shares

Patricia Urge Customers to Exchange Supposed ₦2 Billion Debt for Company Shares

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

DMO Announces Subscription Offering for Federal Government Savings Bonds.

Nigeria Launches N50 Billion Green Bond to Fund Climate-Friendly Projects

June 17, 2025
EFCC Launches Task Force to Combat Naira Mutilation and Dollarization

EFCC Arraigns Precious Williams for Alleged N13.8 Billion Ponzi Scheme Fraud

June 17, 2025

Popular Story

  • World Bank Extends Nigeria’s Digital Identification Project Deadline Amid Missed Targets

    Nigeria Loses $4M World Bank Loan Due to Audit Failure

    0 shares
    Share 0 Tweet 0
  • BlackRock Joins Blockchain Platform Axoni for Equity Swap Trades

    0 shares
    Share 0 Tweet 0
  • Fair Money Job Opening: Regional Sales Manager

    0 shares
    Share 0 Tweet 0
  • Meta plans to cut 11,000 jobs in one of the year’s largest layoffs.

    0 shares
    Share 0 Tweet 0
  • CBN Crackdown: Nigerian Banks Face Dividend Freeze Until 2028

    0 shares
    Share 0 Tweet 0
RateCaptain

RateCaptain

We bring you the most accurate in new and market data. Check our landing page for details.

  • Home
  • About Us
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Cookie Policy
  • Contact Us

Copyright © 2022 RateCaptain - All rights reserved by RateCaptain.

No Result
View All Result
  • Home
    • About Us
    • Contact Us
  • FX Rates
  • Money Market
  • Cryptocurrency
  • Commodities
  • Corporates

Copyright © 2022 RateCaptain - All rights reserved by RateCaptain.

RateCaptain
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
?>